Skip to main content
TipRanks
Go Ultimate75% OFF

VicPlas International Ltd. (569) AI Stock Analysis

5 Followers
SG:569

VicPlas International Ltd.

(SGX:569)

Select Model
Rating:38Underperform
Price Target:SGD 0.06â–¼(-6.45% Downside)
Action:reiterated
Date:10/02/26

The overall stock score of 38 reflects severe fundamental and technical weaknesses. The most significant factors are deeply deteriorating financial health, including collapsing margins and escalating cash burn, coupled with a highly unprofitable valuation. Persistent bearish technical trends further suppress the stock's near-term outlook.

Positive Factors
Revenue ReboundThe sharp latest-year revenue rebound indicates that the company can restore sales after periods of weakness. If maintained, stronger volume or demand would provide a broader base for operating leverage, investment, and eventual earnings recovery over the coming quarters.
Negative Factors
Margin CompressionThe severe gross-margin contraction indicates materially weaker profitability and raises questions about pricing, product mix, or cost control. Unless margins recover, the revenue rebound will translate into limited earnings and leave the company more exposed to operating volatility.

VicPlas International Ltd. (569) vs. iShares MSCI Singapore ETF (EWS)

-40%-30%-20%-10%0%10%20%30%SG:569-32.61%EWS+7.76%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SGD 31.69M
Dividend Yield
―
Average Volume (3M)
107.12K
Price to Earnings (P/E)
-6.2
Beta (1Y)
0.62
Revenue Growth
9.96%
EPS Growth
-119.57%
Country
Singapore
Employees
1,000
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

VicPlas International Ltd. Business Overview & Revenue Model

Company Description

Vicplas International Ltd, established in Singapore in 1993, operates as an investment holding company with key business segments in medical devices and piping systems. The company's geographical reach includes Singapore, Malaysia, the People's Repub...

VicPlas International Ltd. Financial Statement Overview

Summary

Financial performance is severely compromised, characterized by a gross margin collapse from 55.1% to 12.3%, three consecutive years of widening net losses, and persistent negative free cash flow. Escalating debt and declining equity further elevate financial risk.

Income Statement

20Very Negative

Balance Sheet

35Negative

Cash Flow

20Very Negative
Financial statement breakdown
BreakdownTTMJul 2026Jul 2025Jul 2024Jul 2023Jul 2022
Income Statement
Total Revenue127.30M127.30M120.81M102.39M129.22M130.81M
Gross Profit15.61M15.61M66.57M52.42M66.19M68.06M
EBITDA2.97M2.00M8.76M6.93M13.18M17.93M
Net Income-5.14M-5.14M-2.36M-1.36M4.24M8.84M
Balance Sheet
Total Assets147.66M147.66M137.71M131.49M119.02M130.34M
Cash, Cash Equivalents and Short-Term Investments5.93M5.93M4.71M4.97M8.57M8.89M
Total Debt48.44M48.44M41.11M32.47M17.55M28.01M
Total Liabilities80.05M80.05M66.32M56.93M40.46M52.03M
Stockholders Equity67.62M67.62M71.39M74.57M78.56M78.31M
Cash Flow
Free Cash Flow-4.03M-4.03M-5.99M-7.82M12.53M-2.61M
Operating Cash Flow1.40M1.40M388.00K6.72M17.88M10.25M
Investing Cash Flow-5.40M-5.40M-6.36M-14.53M-5.10M-12.79M
Financing Cash Flow5.10M5.10M5.75M4.24M-12.76M1.63M

VicPlas International Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price0.06

Price Trends

50DMA0.07Negative
100DMA0.07Negative
200DMA0.08Negative

Market Momentum

MACD-0.00Negative
RSI24.80Positive
STOCH16.67Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:569, the sentiment is Negative. The current price of 0.06 is above the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.07, and below the 200-day MA of 0.08, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 24.80 is Positive, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:569.

VicPlas International Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

SG:569 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:OTXSG:OTX74OutperformSGD 28.93M8.5319.60%7.81%-3.11%-21.50%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SG:569SG:56938UnderperformSGD 31.69M-6.20-7.55%―9.96%-119.57%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%75%SG:569SG:505SG:546SG:584SG:MIJSG:OTXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SG:569 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SG:569VicPlas International Ltd.0.06-0.03-32.61%
SG:505Asiamedic Limited0.02-0.00-10.53%
SG:546Medtecs International Corporation Ltd.0.10-0.03-22.13%
SG:584AJJ Medtech Holdings Limited0.010.000.00%
SG:MIJAlliance Healthcare Group Ltd.0.180.0655.17%
SG:OTXMedinex Ltd.0.21-0.01-3.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 02, 2026